Bottom line
PHSZX vs JEHSX: the short answer
PHSZX (PGIM Jennison Health Sciences Fund) and JEHSX (Health Sciences Trust) are both mutual funds.
But JEHSX is far broader, holding 173 positions to 55 for PHSZX, so beyond the top names it adds exposure PHSZX doesn't have.
PHSZX is cheaper at 0.88% vs 1.04% — a difference of $16 a year per $10,000 invested.
Over five years, PHSZX returned +7.0% a year vs +4.2% for JEHSX (reporting dates differ).
Updated Nov 19, 2026
PHSZX vs JEHSX side by side
| PHSZX | JEHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | PGIM (Prudential) | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.88% | 1.04% |
| Annual cost per $10k | $88 | $104 |
| 10-yr cost on $10k (prospectus) | $1,084 | $1,282 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0.05% |
| 1-yr return | +19.6% | +19.5% |
| 5-yr return (annualized) | +7.0% | +4.2% |
| 10-yr return (annualized) | +9.8% | +8.7% |
| Best quarter | +29.7% | +23.6% |
| Worst quarter | −20.5% | −16.1% |
| Net assets (fund) | $1.4B | $251.3M |
| Number of holdings | 55 | 173 |
| Portfolio turnover | 81% | 68% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PHSZX | JEHSX | Difference |
|---|---|---|---|
| 2024 | +19.6% | +1.8% | +17.8% |
| 2023 | +8.8% | +4.3% | +4.6% |
| 2022 | +12.6% | −13.1% | +25.7% |
| 2021 | −10.1% | +11.2% | −21.3% |
| 2020 | +6.3% | +27.2% | −20.9% |
| 2019 | +41.7% | +28.7% | +13.0% |
| 2018 | +18.6% | +0.7% | +17.9% |
| 2017 | −3.4% | +27.5% | −30.9% |
| 2016 | +31.4% | −10.6% | +42.0% |
Source: Fund prospectus bar charts
Holdings overlap
9 of PHSZX's top 25 holdings also appear in JEHSX's top 25.
| Holding | PHSZX | JEHSX |
|---|---|---|
| Eli Lilly & Company | 17.35% | 14.30% |
| Merck & Company Inc | 6.06% | 4.21% |
| Unitedhealth Group Inc | 5.87% | 5.95% |
| Thermo Fisher Scientific Inc | 4.56% | 2.67% |
| Vertex Pharmaceuticals Inc | 3.37% | 2.38% |
| Danaher Corp | 3.28% | 1.51% |
| Intuitive Surgical Inc | 3.07% | 1.98% |
| Cvs Health Corp | 2.52% | 0.98% |
| Stryker Corp | 2.16% | 1.87% |
Source: SEC Form N-PORT
PHSZX top 10
- Eli Lilly & Company — 17.35%
- Merck & Company Inc — 6.06%
- Unitedhealth Group Inc — 5.87%
- Thermo Fisher Scientific Inc — 4.56%
- Argenx Se — 3.55%
- Vertex Pharmaceuticals Inc — 3.37%
- Danaher Corp — 3.28%
- Intuitive Surgical Inc — 3.07%
- Lonza Group Ag — 3.02%
- Cvs Health Corp — 2.52%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between PHSZX and JEHSX?
Which is cheaper, PHSZX or JEHSX?
Should I own both PHSZX and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.